GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Buildings And Improvements

SK Bioscience Co (XKRX:302440) Buildings And Improvements : ₩366,735 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co Buildings And Improvements?

SK Bioscience Co's quarterly buildings and improvements increased from Sep. 2024 (₩120,622 Mil) to Dec. 2024 (₩360,585 Mil) and increased from Dec. 2024 (₩360,585 Mil) to Mar. 2025 (₩366,735 Mil).

SK Bioscience Co's annual buildings and improvements declined from Dec. 2022 (₩126,780 Mil) to Dec. 2023 (₩123,276 Mil) but then increased from Dec. 2023 (₩123,276 Mil) to Dec. 2024 (₩360,585 Mil).

SK Bioscience Co Buildings And Improvements Historical Data

The historical data trend for SK Bioscience Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co Buildings And Improvements Chart

SK Bioscience Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buildings And Improvements
Get a 7-Day Free Trial 111,460.81 119,030.53 126,780.40 123,275.61 360,585.23

SK Bioscience Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 122,513.03 121,572.21 120,621.59 360,585.23 366,735.32

SK Bioscience Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

SK Bioscience Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Buildings And Improvements
Comparable Companies
XKRX:145020 XKRX:950160 XKRX:141080 XKRX:298380 XKRX:087010 XKRX:214450 XKRX:310210 XKRX:096530 XKRX:358570 XKRX:347850 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494
Website
https://www.skbioscience.co.kr
SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co Headlines

No Headlines